Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCHR1 | Q99705 | 8/20 | 0.73 |
| ▸ | NCF1 | P14598 | 4/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.46 |
| ▸ | LMNA | P02545 | 3/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | TLR8 | Q9NR97 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | HTR1B | P28222 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10063304 | 0.95 | MCHR1 (0.72) | MCHR1NCF1KDM4ELMNAMAPT | |
| SCHEMBL20696659 | 0.86 | MCHR1 (0.56) | MCHR1LMNAMAPTMEN1NPC1 | |
| SCHEMBL13904506 | 0.86 | MCHR1 (0.68) | MCHR1NCF1KDM4ELMNAMAPT | |
| SCHEMBL20696658 | 0.84 | MCHR1 (0.54) | MCHR1NCF1KDM4ETLR8MEN1 | |
| SCHEMBL5883752 | 0.84 | MCHR1 (1.00) | MCHR1NCF1 | |
| SCHEMBL28065654 | 0.84 | MCHR1 (0.72) | MCHR1NCF1KDM4ELMNAMAPT | |
| SCHEMBL10682868 | 0.84 | MCHR1 (0.72) | MCHR1NCF1KDM4ELMNAMAPT | |
| SCHEMBL5884086 | 0.83 | MCHR1 (1.00) | MCHR1NCF1 | |
| SCHEMBL7259257 | 0.83 | MCHR1 (1.00) | MCHR1NCF1 | |
| SCHEMBL9568616 | 0.82 | MAPT (0.66) | MCHR1KDM4ELMNAMAPTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2456793-A1 | CATALYSTS BASED ON 2-(2-ARYLOXY) QUINOLINE OR 2-(2-ARYLOXY) DIHYDROQUNIOLINE LIGANDS | Equistar Chemicals, LP (US) | 2012-05-30 | — | — | EP | claimed |
| EP-2456795-A1 | METHOD OF PREPARING NON-METALLOCENE CATALYSTS | Equistar Chemicals, LP (US) | 2012-05-30 | — | — | EP | claimed |
| US-8158733-B2 | Catalysts based on 2-(2-aryloxy)quinoline or 2-(2-aryloxy)dihydroquinoline ligands | EQUISTAR CHEMICALS, LP (US) | 2012-04-17 | — | — | US | claimed |
| WO-2011011039-A1 | METHOD OF PREPARING NON-METALLOCENE CATALYSTS | EQUISTAR CHEMICALS, LP (US) | 2011-01-27 | — | — | WO | claimed |
| US-20110021344-A1 | Method for preparing non-metallocene ligands | EQUISTAR CHEMICALS, LP | 2011-01-27 | — | — | US | claimed |
| US-20110021727-A1 | Catalysts based on 2-(2-aryloxy)quinoline or 2-(2-aryloxy)dihydroquinoline ligands | EQUISTAR CHEMICALS, LP | 2011-01-27 | — | — | US | claimed |
| WO-2011011040-A1 | CATALYSTS BASED ON 2-(2-ARYLOXY) QUINOLINE OR 2-(2-ARYLOXY) DIHYDROQUNIOLINE LIGANDS | EQUISTAR CHEMICALS, LP (US) | 2011-01-27 | — | — | WO | claimed |
| EP-3478694-B9 | QUINOLINYLDIAMIDO TRANSITION METAL COMPLEXES, PRODUCTION AND USE THEREOF | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2021-08-04 | — | — | EP | disclosed |
| EP-3478694-B1 | QUINOLINYLDIAMIDO TRANSITION METAL COMPLEXES, PRODUCTION AND USE THEREOF | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2020-12-09 | — | — | EP | disclosed |
| US-10815318-B2 | Quinolinyldiamido transition metal complexes, production and use thereof | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2020-10-27 | — | — | US | disclosed |
| US-10562987-B2 | Polymers produced via use of quinolinyldiamido transition metal complexes and vinyl transfer agents | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2020-02-18 | — | — | US | disclosed |
| US-20190177449-A1 | Quinolinyldiamido Transition Metal Complexes, Production and Use Thereof | EXXONMOBIL CHEMICAL PATENTS INC. | 2019-06-13 | — | — | US | disclosed |
| EP-3478694-A1 | QUINOLINYLDIAMIDO TRANSITION METAL COMPLEXES, PRODUCTION AND USE THEREOF | ExxonMobil Chemical Patents Inc. (US) | 2019-05-08 | — | — | EP | disclosed |
| EP-2456795-A1 | METHOD OF PREPARING NON-METALLOCENE CATALYSTS | Equistar Chemicals, LP (US) | 2012-05-30 | — | — | EP | disclosed |
| US-8158733-B2 | Catalysts based on 2-(2-aryloxy)quinoline or 2-(2-aryloxy)dihydroquinoline ligands | EQUISTAR CHEMICALS, LP (US) | 2012-04-17 | — | — | US | disclosed |
| US-8153544-B2 | Method for preparing non-metallocene catalysts | EQUISTAR CHEMICALS, LP (US) | 2012-04-10 | — | — | US | disclosed |
| WO-2011011039-A1 | METHOD OF PREPARING NON-METALLOCENE CATALYSTS | EQUISTAR CHEMICALS, LP (US) | 2011-01-27 | — | — | WO | disclosed |
| US-20110021344-A1 | Method for preparing non-metallocene ligands | EQUISTAR CHEMICALS, LP | 2011-01-27 | — | — | US | disclosed |
| US-20110021727-A1 | Catalysts based on 2-(2-aryloxy)quinoline or 2-(2-aryloxy)dihydroquinoline ligands | EQUISTAR CHEMICALS, LP | 2011-01-27 | — | — | US | disclosed |
| WO-2011011040-A1 | CATALYSTS BASED ON 2-(2-ARYLOXY) QUINOLINE OR 2-(2-ARYLOXY) DIHYDROQUNIOLINE LIGANDS | EQUISTAR CHEMICALS, LP (US) | 2011-01-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10815318-B2 | Quinolinyldiamido transition metal complexes, production and use thereof | PARN, PARG, PICALM | MCHR1 4740/4885NCF1 1493/4885KDM4E 4392/4885 |
| US-20190177449-A1 | Quinolinyldiamido Transition Metal Complexes, Production and Use Thereof | PARN, PARG, PICALM | MCHR1 4740/4885NCF1 1493/4885KDM4E 4392/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.